Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
International Journal of Molecular Sciences
|
August 7, 2021
Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective
Cristina Hernando, Belén Ortega-Morillo, Marta Tapia, et al.
ACS Applied Materials & Interfaces
|
August 7, 2023
Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy
Iris Garrido-Cano, Anna Adam-Artigues, Ana Lameirinhas, et al.
Scientific Reports
|
March 31, 2019
The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors
Eduardo Tormo, Sandra Ballester, Anna Adam-Artigues, et al.
ACS Infectious Diseases
|
November 3, 2024
Global Health Priority Box─Proactive Pandemic Preparedness
Anna Adam, Dominique Besson, Rob Bryant, et al.
International Journal of Molecular Sciences
|
October 14, 2020
Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer
Iris Garrido-Cano, Vera Constâncio, Anna Adam-Artigues, et al.
Cancer Communications (London, England)
|
August 23, 2022
miR-99a-5p modulates doxorubicin resistance via the COX-2/ABCG2 axis in triple-negative breast cancer: from the discovery to in vivo studies
Iris Garrido-Cano, Anna Adam-Artigues, Ana Lameirinhas, et al.
ACS Infectious Diseases
|
March 14, 2022
The Pandemic Response Box─Accelerating Drug Discovery Efforts after Disease Outbreaks
Kirandeep Samby, Dominique Besson, Anirban Dutta, et al.
Frontiers in Oncology
|
October 5, 2020
MicroRNA-33b Suppresses Epithelial-Mesenchymal Transition Repressing the MYC-EZH2 Pathway in HER2+ Breast Carcinoma
Birlipta Pattanayak, Iris Garrido-Cano, Anna Adam-Artigues, et al.
Cancers
|
April 13, 2023
miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer
Paula Cabello, Sandra Torres-Ruiz, Anna Adam-Artigues, et al.
Cancers
|
July 2, 2021
Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast Cancer
Anna Adam-Artigues, Iris Garrido-Cano, Juan Antonio Carbonell-Asins, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
International Journal of Molecular Sciences
|
August 7, 2021
Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective
Cristina Hernando, Belén Ortega-Morillo, Marta Tapia, et al.
ACS Applied Materials & Interfaces
|
August 7, 2023
Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy
Iris Garrido-Cano, Anna Adam-Artigues, Ana Lameirinhas, et al.
Scientific Reports
|
March 31, 2019
The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors
Eduardo Tormo, Sandra Ballester, Anna Adam-Artigues, et al.
ACS Infectious Diseases
|
November 3, 2024
Global Health Priority Box─Proactive Pandemic Preparedness
Anna Adam, Dominique Besson, Rob Bryant, et al.
International Journal of Molecular Sciences
|
October 14, 2020
Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer
Iris Garrido-Cano, Vera Constâncio, Anna Adam-Artigues, et al.
Cancer Communications (London, England)
|
August 23, 2022
miR-99a-5p modulates doxorubicin resistance via the COX-2/ABCG2 axis in triple-negative breast cancer: from the discovery to in vivo studies
Iris Garrido-Cano, Anna Adam-Artigues, Ana Lameirinhas, et al.
ACS Infectious Diseases
|
March 14, 2022
The Pandemic Response Box─Accelerating Drug Discovery Efforts after Disease Outbreaks
Kirandeep Samby, Dominique Besson, Anirban Dutta, et al.
Frontiers in Oncology
|
October 5, 2020
MicroRNA-33b Suppresses Epithelial-Mesenchymal Transition Repressing the MYC-EZH2 Pathway in HER2+ Breast Carcinoma
Birlipta Pattanayak, Iris Garrido-Cano, Anna Adam-Artigues, et al.
Cancers
|
April 13, 2023
miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer
Paula Cabello, Sandra Torres-Ruiz, Anna Adam-Artigues, et al.
Cancers
|
July 2, 2021
Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast Cancer
Anna Adam-Artigues, Iris Garrido-Cano, Juan Antonio Carbonell-Asins, et al.
Page
of 3